Peter Traber is an accomplished medical professional and consultant with extensive experience in clinical development and drug strategy across various therapeutic areas, particularly in fibrotic disease, hepatology, and immunology. Currently serving as a Senior Clinical Consultant at Cartesian Therapeutics and Sobi, Peter Traber provides expertise on BLA submissions and supports the combined clinical development of Selecta and Cartesian. Additionally, Peter Traber is the President of PGT Life Sciences Consulting and an Adjunct Professor of Medicine at the University of Pennsylvania School of Medicine. Previous roles include Chief Medical Officer at Selecta Biosciences and leadership positions at Galectin Therapeutics Inc. and Baylor College of Medicine, as well as significant tenures at GlaxoSmithKline and Alacrita Consulting. Peter Traber holds a BS in Chemical Engineering and an MD, alongside board certifications in Internal Medicine, Gastroenterology, and Hepatology.
This person is not in any teams
This person is not in any offices